Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
GSK’s consumer health business trades down on London debut -
Vaccine financier marketing trade amid major disruption in UK politics
-
UK real estate income trust prices open-ended deal
-
Some call €630m deal a hybrid between private debt and traditional syndication
-
UK real estate fund last raised £40m in February
-
Coloplast gains attention for M&A loan refinancing but markets are ugly
